Pathogenesis of Borrelia miyamotoi infection and Lyme coinfection in mice

小鼠宫本疏螺旋体感染和莱姆病合并感染的发病机制

基本信息

  • 批准号:
    10059164
  • 负责人:
  • 金额:
    $ 41.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-12-01 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Borrelia miyamotoi is a newly emerging relapsing fever (RF) spirochete transmitted by Ixodes tick spp that also transmit the Lyme disease agent Borrelia burgdorferi. B. miyamotoi has recently been found to cause human disease in areas where Lyme disease is endemic. Our group has isolated B. miyamotoi from a person with disseminated Lyme disease, demonstrating that coinfection of B. miyamotoi and B. burgdorferi is occurring. The full spectrum of B. miyamotoi-associated disease is not known, however other RF Borrelia cause blood disorders, multiorgan system dysfunction, and fetal demise in humans. This project will use a mouse model to define B. miyamotoi pathogenesis, host immune responses and risk factors for disease, and to examine the impact of B. miyamotoi/B. burgdorferi coinfection on disease associated with each of these pathogens. Studies will be conducted with our clinical isolate of I. scapularis-borne B. miyamotoi from Connecticut and a newly generated tick isolate from Wisconsin. The duration of tick attachment for B. miyamotoi transmission will be determined as well as kinetics of bacteremia, spectrum of disease and sites of persistence. As the greatest B. miyamotoi diversity is seen among isolates from different Ixodes spp, we will evaluate disease expression after infection with an I. pacificus-borne B. miyamotoi isolate. Studies in immunodeficient mice and mice with altered immunity due to splenectomy, immunosuppressive agents, and pregnancy will be conducted to delineate risk factors for more severe disease and adverse maternal-fetal outcomes. Based on preliminary data, we hypothesize that the early innate defense against B. miyamotoi may differ from other RF Borrelia. We will employ the advanced technology of cytokine time-of-flight mass spectrometry (CyTOF) to broadly immunophenotype responding cells and the cytokines they produce during infection. We will determine whether antibodies elicited by infection can prevent challenge infection in a naïve host or in the same host challenged with tick-transmitted spirochetes. We will assess the impact of B. burgdorferi/B. miyamotoi coinfection on disease expression associated with each of these pathogens. CyTOF will be conducted to phenotypically and functionally characterize the host immune response to coinfection with B. miyamotoi and B. burgdorferi, pathogens that thrive differentially in blood and connective tissue. The results of these studies will provide clinically useful information regarding tick transmission dynamics, B. miyamotoi tissue tropism and disease, and immune correlates of protection to predict risk factors for human disease and adverse outcomes. !
项目摘要 宫本疏螺旋体是一种新出现的回归热(RF)螺旋体,由硬蜱属传播,也 传播莱姆病病原体伯氏疏螺旋体。B。宫本最近被发现会导致人类 莱姆病流行地区的疾病。我们小组已经隔离了B。宫本井从一个人与 播散性莱姆病,表明B. miyamotoi和B. Burgdorferi正在发生。 B的全光谱。miyamotoi相关的疾病是未知的,但是其他RF疏螺旋体引起血液 疾病、多器官系统功能障碍和胎儿死亡。这个项目将使用鼠标模型, 定义B。miyamotoi发病机制,宿主免疫反应和疾病的危险因素,并检查 B的影响。宫本/B。与这些病原体中的每一种相关的疾病。研究 将用我们的临床分离株I.肩胛骨承载B。来自康涅狄格州的miyamotoi和一个新的 从威斯康星州分离出蜱虫。B的蜱附着持续时间。Miyamotoi传输将是 确定以及菌血症的动力学、疾病谱和持久性位点。最伟大的B。 在来自不同硬蜱属的分离株中观察到miyamotoi多样性,我们将在 感染I.太平洋传播B.宫本分离物。在免疫缺陷小鼠和患有 由于脾切除术、免疫抑制剂和妊娠引起的免疫改变将进行, 描述更严重疾病和不良母胎结局的风险因素。根据初步 数据,我们假设,早期先天防御B。miyamotoi可能不同于其他RF疏螺旋体。我们 将采用先进的细胞因子飞行时间质谱(CyTOF)技术, 免疫表型反应细胞及其在感染期间产生的细胞因子。我们将确定 感染引起的抗体是否可以预防初始宿主或同一宿主的攻毒感染 被蜱虫传播的螺旋体感染我们将评估B的影响。burgdorferi/B.宫本井 共感染对与这些病原体中的每一种相关的疾病表达的影响。将进行CyTOF, 表型和功能上表征了宿主对与B共感染的免疫应答。miyamotoi和B. burgdorferi,在血液和结缔组织中生长差异的病原体。这些研究的结果将 提供关于蜱传播动力学的临床有用信息,B。宫本氏组织向性和 疾病和免疫保护的相关性,以预测人类疾病和不良后果的风险因素。 !

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linda K. Bockenstedt其他文献

Ballistic Motion of Spirochete Membrane Proteins
  • DOI:
    10.1016/j.bpj.2010.12.3013
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Holger Kress;Rostislav Boltyanskiy;Alexia A. Belperron;Cecile O. Mejean;Charles W. Wolgemuth;Linda K. Bockenstedt;Eric R. Dufresne
  • 通讯作者:
    Eric R. Dufresne

Linda K. Bockenstedt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Linda K. Bockenstedt', 18)}}的其他基金

Immunophenotypic analysis of the cutaneous humoral response in early Lyme disease
早期莱姆病皮肤体液反应的免疫表型分析
  • 批准号:
    10451111
  • 财政年份:
    2022
  • 资助金额:
    $ 41.88万
  • 项目类别:
Immunophenotypic analysis of the cutaneous humoral response in early Lyme disease
早期莱姆病皮肤体液反应的免疫表型分析
  • 批准号:
    10561695
  • 财政年份:
    2022
  • 资助金额:
    $ 41.88万
  • 项目类别:
Pathogenesis of Borrelia miyamotoi infection and Lyme coinfection in mice
小鼠宫本疏螺旋体感染和莱姆病合并感染的发病机制
  • 批准号:
    10303049
  • 财政年份:
    2017
  • 资助金额:
    $ 41.88万
  • 项目类别:
13th International Conference on Lyme Borreliosis and Other Tick-borne Diseases
第十三届莱姆疏螺旋体病和其他蜱传疾病国际会议
  • 批准号:
    8459172
  • 财政年份:
    2013
  • 资助金额:
    $ 41.88万
  • 项目类别:
A New Cytokine-Based Immunoassay for the Diagnosis of Lyme Disease
用于诊断莱姆病的新的基于细胞因子的免疫测定法
  • 批准号:
    8301247
  • 财政年份:
    2012
  • 资助金额:
    $ 41.88万
  • 项目类别:
A New Cytokine-Based Immunoassay for the Diagnosis of Lyme Disease
用于诊断莱姆病的新的基于细胞因子的免疫测定法
  • 批准号:
    8466282
  • 财政年份:
    2012
  • 资助金额:
    $ 41.88万
  • 项目类别:
A New Cytokine-Based Immunoassay for the Diagnosis of Lyme Disease
用于诊断莱姆病的新的基于细胞因子的免疫测定法
  • 批准号:
    8877395
  • 财政年份:
    2012
  • 资助金额:
    $ 41.88万
  • 项目类别:
A New Cytokine-Based Immunoassay for the Diagnosis of Lyme Disease
用于诊断莱姆病的新的基于细胞因子的免疫测定法
  • 批准号:
    8839960
  • 财政年份:
    2012
  • 资助金额:
    $ 41.88万
  • 项目类别:
T cell cytokine assay for the diagnosis of disseminated Lyme borreliosis
T 细胞细胞因子测定用于诊断播散性莱姆疏螺旋体病
  • 批准号:
    8058201
  • 财政年份:
    2011
  • 资助金额:
    $ 41.88万
  • 项目类别:
Real-time Imaging Analysis of Vector-borne Lyme Borreliosis Pathogenesis & Persis
媒介传播莱姆疏螺旋体病发病机制的实时成像分析
  • 批准号:
    8424969
  • 财政年份:
    2010
  • 资助金额:
    $ 41.88万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 41.88万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了